Sometimes, in order to understand what’s happening in the immune system, you just have to watch it. By imaging the immune response, researchers have observed how two types of immune cells, T and B cells, interact with one another during a critical period following infection in order to prepare the best antibodies and establish long-lasting protection.
Their surprising finding: T cells and B cells form numerous short-term contacts, each lasting no more than a few minutes, in a dynamic process that is very different from how T cells interact with other cell types. The results were recently published in Science.
shulman BTcells from Newswise on Vimeo.
Connecting. A time-lapse movie shows T cells (red) and B cells (blue) making contact (green) within a mouse germinal center. Interaction between the two types of cells drives the process of diversification, in which B cells are selected based on the effectiveness of the antibodies they produce.
The action takes place in so-called germinal centers, tiny structures within the body’s lymphatic system where B cells learn to make antibodies against specific microbes. Within these sites B cells undergo a process known as diversification in which they experience rapid mutations in the genes that encode antibodies. Only the best B cells — those with the highest “affinities” — are selected to leave the germinal centers and become antibody-secreting cells.
“In the germinal centers, T cells discern between B cells that are making effective antibodies and those that are not — it is because of their scrutiny that the immune system learns to take the correct action to fight off infection,” says study author Ziv Shulman, a postdoc in Michel C. Nussenzweig’s Laboratory of Molecular Immunology. “But nobody had ever observed directly and described the dynamics of this process and little is known about how T cells make their determination.”
Nussenzweig, who is Zanvil A. Cohn and Ralph M. Steinman Professor, along with Shulman, and their colleagues, developed a system in which they could observe the germinal centers directly in live mice under physiological conditions, tagging T cells and B cells with separate fluorescent proteins that allowed them to track the movements of the cells in real time. They also developed an algorithm that could process the resulting videos and keep precise track of the quantity of contacts between the two cell types as well as the duration of each contact.
They found that the amount of antigen being picked up by B cells with high affinity antibodies and presented to T cells dictates the duration of interaction between the cells. In these contacts, the B cells are instructed either to differentiate into antibody secreting cells or to undergo further mutation.
To test whether the cells were indeed communicating with one another, the researchers also visualized the amount of free calcium within the cells. They found an increase in intracellular calcium, an indicator of signaling events triggered during the T and B cells interactions. Furthermore, the dynamics of the calcium signaling they observed suggests that not only are T cells telling B cells what to do, but that the flow of information is bi-directional: T cells are also learning from B cells.
“The transient interactional dynamics allow T cells to continuously seek and find B cells that are presenting high levels of antigen and provide them with preferential help, while still permitting competing B cells to mutate and develop,” Shulman says. “It’s an interactive process, with B cells being directed by T cells and T cells learning from their interactions with B cells.”
The research team says that a better understanding of the processes that take place in germinal centers could lead to new ways to manipulate them in order to more effectively harness the body’s immune system to develop vaccines and fight a variety of diseases.
Zach Veilleux | newswise
Lethal combination: Drug cocktail turns off the juice to cancer cells
12.12.2018 | Universität Basel
Smelling the forest – not the trees
12.12.2018 | Universität Konstanz
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
12.12.2018 | Health and Medicine
12.12.2018 | Physics and Astronomy
12.12.2018 | Health and Medicine